Evidence for communication of peripheral iron status to cerebrospinal fluid: clinical implications for therapeutic strategy.
BBB
CSF
Hemoglobin
Iron
Restless legs syndrome
Serum ferritin
Transferrin
Journal
Fluids and barriers of the CNS
ISSN: 2045-8118
Titre abrégé: Fluids Barriers CNS
Pays: England
ID NLM: 101553157
Informations de publication
Date de publication:
16 Apr 2020
16 Apr 2020
Historique:
received:
07
01
2020
accepted:
04
04
2020
entrez:
17
4
2020
pubmed:
17
4
2020
medline:
1
12
2020
Statut:
epublish
Résumé
Iron is crucial for proper functioning of all organs including the brain. Deficiencies and excess of iron are common and contribute to substantial morbidity and mortality. Whereas iron's involvement in erythropoiesis drives clinical practice, the guidelines informing interventional strategies for iron repletion in neurological disorders are poorly defined. The objective of this study was to determine if peripheral iron status is communicated to the brain. We used a bi-chamber cell culture model of the blood-brain-barrier to determine transcytosis of iron delivered by transferrin as a metric of iron transport. In the apical chamber (representative of the blood) we placed transferrin complexed with iron We demonstrate that iron transport correlates positively with plasma hemoglobin concentrations but not serum ferritin levels. The clinical ramifications of these findings are several- fold. They suggest that erythropoietic demands for iron take precedence over brain requirements, and that the metric traditionally considered to be the most specific test reflecting total body iron stores and relied upon to inform treatment decisions-i.e., serum ferritin-may not be the preferred peripheral indicator when attempting to promote brain iron uptake. The future direction of this line of investigation is to identify the factor(s) in the CSF that influence iron transport at the level of the BBB.
Sections du résumé
BACKGROUND
BACKGROUND
Iron is crucial for proper functioning of all organs including the brain. Deficiencies and excess of iron are common and contribute to substantial morbidity and mortality. Whereas iron's involvement in erythropoiesis drives clinical practice, the guidelines informing interventional strategies for iron repletion in neurological disorders are poorly defined. The objective of this study was to determine if peripheral iron status is communicated to the brain.
METHODS
METHODS
We used a bi-chamber cell culture model of the blood-brain-barrier to determine transcytosis of iron delivered by transferrin as a metric of iron transport. In the apical chamber (representative of the blood) we placed transferrin complexed with iron
RESULTS
RESULTS
We demonstrate that iron transport correlates positively with plasma hemoglobin concentrations but not serum ferritin levels.
CONCLUSIONS
CONCLUSIONS
The clinical ramifications of these findings are several- fold. They suggest that erythropoietic demands for iron take precedence over brain requirements, and that the metric traditionally considered to be the most specific test reflecting total body iron stores and relied upon to inform treatment decisions-i.e., serum ferritin-may not be the preferred peripheral indicator when attempting to promote brain iron uptake. The future direction of this line of investigation is to identify the factor(s) in the CSF that influence iron transport at the level of the BBB.
Identifiants
pubmed: 32295615
doi: 10.1186/s12987-020-00190-8
pii: 10.1186/s12987-020-00190-8
pmc: PMC7161256
doi:
Substances chimiques
Hemoglobins
0
Transferrin
0
Ferritins
9007-73-2
Iron
E1UOL152H7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
28Subventions
Organisme : NINDS NIH HHS
ID : R01 NS113912
Pays : United States
Organisme : Foundation for the National Institutes of Health
ID : 1R01NS089719
Organisme : NINDS NIH HHS
ID : 1R01NS113912
Pays : United States
Références
World J Gastroenterol. 2016 Sep 21;22(35):7908-25
pubmed: 27672287
J Cereb Blood Flow Metab. 2015 Jan;35(1):48-57
pubmed: 25315861
Ann Biomed Eng. 2010 Aug;38(8):2499-511
pubmed: 20361260
Pediatr Res. 2016 Jun;79(6):922-8
pubmed: 26866907
J Pharm Sci. 1993 Aug;82(8):804-7
pubmed: 8377118
Dan Med J. 2014 Apr;61(4):B4824
pubmed: 24814598
Sleep Med. 2011 Oct;12(9):906-13
pubmed: 21978726
Food Nutr Bull. 2007 Dec;28(4 Suppl):S560-71
pubmed: 18297894
Curr Opin Cardiol. 2020 Mar;35(2):133-137
pubmed: 31904605
Arch Med Res. 2018 Aug;49(6):405-417
pubmed: 30573199
Sleep. 2019 May 1;42(5):
pubmed: 30722056
Obes Rev. 2015 Dec;16(12):1081-93
pubmed: 26395622
Sleep Med. 2014 Dec;15(12):1473-6
pubmed: 25441748
J Gen Intern Med. 1992 Mar-Apr;7(2):145-53
pubmed: 1487761
J Biol Inorg Chem. 2019 Dec;24(8):1141-1157
pubmed: 31650248
Brain. 2011 Apr;134(Pt 4):959-68
pubmed: 21398376
Pediatr Res. 1989 Nov;26(5):467-9
pubmed: 2812898
Clin Chem. 1998 Jan;44(1):45-51
pubmed: 9550557
Am J Physiol. 1997 Dec;273(6):R2124-31
pubmed: 9435670
J Clin Neurophysiol. 2001 Mar;18(2):128-47
pubmed: 11435804
Mayo Clin Proc. 2013 Sep;88(9):977-86
pubmed: 24001490